Clinical Trial Update: Calmodulin Gene Mutations in Patients With Ventricular Arrhythmia of Unknown Origin - A Screening Study

View source ↗

Summary

A clinical trial screening study investigating calmodulin gene mutations in patients with ventricular tachycardia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ventricular Tachycardia

Snippet

Sponsor: Region Örebro County | Conditions: Ventricular Tachycardia | Status: WITHDRAWN